Demonstrates electron spatially fractionated radiation therapy using a 3D-printed GRID, suggesting a promising alternative for clinical applications.
This study demonstrates the feasibility of eSFRT using a 3D-printed TS GRID collimator to deliver superficial, spatially heterogeneous doses. TS provides reproducible geometry, mechanical stability, and biocompatibility, making it a clinically translatable alternative to lead, TFP, and TCR GRID collimators warranting further preclinical and clinical investigation.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: